Cost reduction in screening for retinopathy of prematurity in the Netherlands by comparing different screening strategies.
Kasia TrzcionkowskaNicoline E Schalij-DelfosElske M E van den Akker-van MarlePublished in: Acta ophthalmologica (2022)
The current Dutch ROP guideline can be improved by implementing new screening inclusion criteria. The most effective strategy detecting all severe and treated infants, reduces the number of screened infants by 24% compared to the current guideline and the overall annual costs by €59454.